Developer docs
API playgroundTry for free, no card

Search company profiles

University Hospitals Coventry and Warwickshire NHS Trust

Full company profile

uuid0003k1a

Namestring
University Hospitals Coventry and Warwickshire NHS Trust
Legal namestring
University Hospitals Coventry and Warwickshire NHS Trust
Websiteurl
uhcw.nhs.uk
Company typeenum
Private
Founded yearint
2000
Descriptiontext

University Hospitals Coventry and Warwickshire NHS Trust (UHCW) is a public-sector NHS acute hospital trust operating two major hospitals — University Hospital in Coventry and Hospital of St Cross in Rugby — together with community services including the City of Coventry Health Centre. Founded in 1992 (Trust formally established 2000), it serves a population of over one million people across Coventry and Warwickshire in the West Midlands, delivering the full range of NHS secondary and tertiary services: emergency medicine, elective and trauma surgery, maternity, cancer treatment, interventional radiology, reproductive medicine, diabetes and endocrinology services via the WISDEM centre, and a multi-disciplinary radiology service performing over 350,000 diagnostic examinations per year across 4 CT scanners, 4 MRI scanners, ultrasound, X-ray, and PET-CT modalities.

The trust operates a proprietary digital stack including the Electronic Patient Record with Integrated Care Record interoperability, the myhealth Coventry and Warwickshire patient portal, live waiting time dashboards, and the HEARTT (Health Equity and the Right to Treatment) analytics tool developed in-house by the Performance and Informatics team. It was the first healthcare organisation in Europe to leverage process mining effectively via a partnership with IBM and Celonis, and in November 2024 became the first UK trust to deploy the AURA 10 mobile PET-CT imager (from Belgian vendor XEOS) for intraoperative tumor margin assessment during cancer surgery as part of the eXcision study.

Revenue is derived almost exclusively from NHS England commissioning via the Coventry and Warwickshire Integrated Care System, with services provided free at the point of use and a small private patient income stream via the Centre for Reproductive Medicine. The trust is governed as a public benefit entity with no external shareholders, and supplements public funding through the UHCW Charity and donations (such as Friends of St Cross contributions to the Fern Unit). Research is conducted via strategic partnerships with the University of Warwick, Warwick Medical School, University of Nottingham, and Imperial College London, and in January 2026 the trust co-launched VerIQ Limited, a University of Warwick spin-out focused on accelerating medtech and orthopaedics clinical trials across the UK.

Short descriptiontext

University Hospitals Coventry and Warwickshire NHS Trust is a public NHS acute hospital trust operating University Hospital Coventry and Hospital of St Cross Rugby, delivering comprehensive secondary and tertiary care to over one million residents in the West Midlands under NHS England commissioning.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersCoventry, United Kingdom
HQ citystring
Coventry
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
acute hospital services, emergency medical care, diagnostic imaging services, cancer treatment services, maternity healthcare services
Industry1 code
1Faith-Based & Nonprofit Hospital Systems
CodeHLAFAAAEPrimaryYes
NAICS code3 codes
  • General Medical and Surgical Hospitals6221
  • General Medical and Surgical Hospitals622110
  • Hospitals622
SIC code2 codes
  • Services-Hospitals8060
  • Services-General Medical & Surgical Hospitals, Nec8062
Product category
Acute Hospital Healthcare Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1NHS Core Funding
TypeManaged Services
Description

Core funding from the UK National Health Service through NHS England and NHS commissioning. Services are commissioned based on population health needs through the Coventry and Warwickshire Integrated Care System.

uhcw.nhs.uk
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 3 records shown
1UHCW Charity
Description

Charitable arm of the trust supporting hospital services and equipment

uhcw.nhs.uk
+2 more records
Core offering1 text field

University Hospitals Coventry and Warwickshire NHS Trust (UHCW) operates two major NHS hospitals (University Hospital Coventry and Hospital of St Cross, Rugby) delivering comprehensive acute, emergency, elective, maternity, cancer, and specialist clinical services to a population of over one million people across Coventry and Warwickshire. The trust provides diagnostic imaging, interventional radiology, surgery, and specialized services including reproductive medicine, diabetes/endocrinology, and voice/swallowing care. It also conducts clinical research, trials, and innovation projects in partnership with UK universities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 350,000+ diagnostic examinations performed annually across all imaging modalities
+2 more records
Product overview1 text field

University Hospitals Coventry and Warwickshire NHS Trust operates as a large NHS hospital trust managing two major hospitals (University Hospital, Coventry and Hospital of St. Cross, Rugby) serving over a million people. The trust provides a comprehensive range of clinical services including emergency medicine, surgery, maternity, cancer care, and specialized services such as the Centre for Reproductive Medicine (IVF), WISDEM (diabetes/endocrinology/obesity), and interventional radiology. The trust has developed digital patient services including the myhealth Coventry and Warwickshire patient portal for online appointment booking and health records access, live waiting times tracking, and electronic patient record systems. The Performance & Informatics department has developed proprietary health technology tools including the HEARTT tool for health equity and waiting list management.

Product and service6 records
1Centre for Reproductive Medicine
CategorySpecialized Clinical Service
2WISDEM
CategorySpecialized Clinical Service
3Coventry Voice, Swallowing and Airway Centre (CVASC)
CategorySpecialized Clinical Service
4Radiology Services
CategoryClinical Diagnostic Service
5Interventional Radiology
CategoryClinical Service
6myhealth Coventry and Warwickshire Patient Portal
CategoryDigital Patient Service
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-11
Description

Launched VerIQ Limited, a spin-out company in partnership with UHCW NHS Trust to accelerate the design, initiation, and delivery of clinical trials for medical devices and health technologies across the UK. Creating an integrated national clinical trial platform focused initially on orthopaedics and wider medtech trials.

2Warwick Medical School
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partnership with researchers from University Hospitals Coventry and Warwickshire and Warwick Medical School presenting GLP-1 drug findings at ENDO 2026 conference.

miragenews.com
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Led the FreeDM2 clinical trial on continuous glucose monitoring for type 2 diabetes, with findings published in The Lancet Diabetes and Endocrinology.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Co-led the FreeDM2 clinical trial on continuous glucose monitoring for type 2 diabetes.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

University of Warwick-led study evaluating the Gro Health W8Buddy digital weight management pathway, NIHR-funded real-world patient-choice study recruiting 450 participants.

6Friends of St Cross
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Charitable organization that donates equipment and volunteers to support the Hospital of St Cross. Donated over £70,000 to support the Fern Unit including a new ultrasound machine and two ultrasound couches.

uhcw.nhs.uk
Strategic tierCoreTypeTechnology or Integration
Description

Manufacturer of the AURA 10 mobile PET-CT imager, first used in the UK at UHCW for intraoperative tumor margin assessment during cancer surgery.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partner trust in the SHiP-Rt study on shortened high-dose palliative radiotherapy for lung cancer.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partner trust in the SHiP-Rt study on shortened high-dose palliative radiotherapy for lung cancer.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partner trust in the SHiP-Rt study on shortened high-dose palliative radiotherapy for lung cancer.

11Warwick Medical School
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Contributing oncologists, clinical scientists, radiotherapy physicists and radiobiology experts to the SHiP-Rt study.

uhcw.nhs.uk
12IBM
Strategic tierMajorTypeTechnology or Integration
Description

Collaborative partner in developing the HEARTT tool and outpatient transformation, winning HSJ Best Healthcare Analytics Award 2024.

Strategic tierMajorTypeTechnology or Integration
Description

Partner in process mining for healthcare, enabling UHCW to become the first healthcare organization in Europe to leverage data mining effectively.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

System partnership coordinating health and care services across the region, working with P&I Informatics team for timely and accurate intelligence.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

University Hospitals Coventry and Warwickshire NHS Trust

Acute Hospital Healthcare Servicesuhcw.nhs.uk

University Hospitals Coventry and Warwickshire NHS Trust is a public NHS acute hospital trust operating University Hospital Coventry and Hospital of St Cross Rugby, delivering comprehensive secondary and tertiary care to over one million residents in the West Midlands under NHS England commissioning.

What University Hospitals Coventry and Warwickshire NHS Trust does

University Hospitals Coventry and Warwickshire NHS Trust (UHCW) is a public-sector NHS acute hospital trust operating two major hospitals — University Hospital in Coventry and Hospital of St Cross in Rugby — together with community services including the City of Coventry Health Centre. Founded in 1992 (Trust formally established 2000), it serves a population of over one million people across Coventry and Warwickshire in the West Midlands, delivering the full range of NHS secondary and tertiary services: emergency medicine, elective and trauma surgery, maternity, cancer treatment, interventional radiology, reproductive medicine, diabetes and endocrinology services via the WISDEM centre, and a multi-disciplinary radiology service performing over 350,000 diagnostic examinations per year across 4 CT scanners, 4 MRI scanners, ultrasound, X-ray, and PET-CT modalities.

The trust operates a proprietary digital stack including the Electronic Patient Record with Integrated Care Record interoperability, the myhealth Coventry and Warwickshire patient portal, live waiting time dashboards, and the HEARTT (Health Equity and the Right to Treatment) analytics tool developed in-house by the Performance and Informatics team. It was the first healthcare organisation in Europe to leverage process mining effectively via a partnership with IBM and Celonis, and in November 2024 became the first UK trust to deploy the AURA 10 mobile PET-CT imager (from Belgian vendor XEOS) for intraoperative tumor margin assessment during cancer surgery as part of the eXcision study.

Revenue is derived almost exclusively from NHS England commissioning via the Coventry and Warwickshire Integrated Care System, with services provided free at the point of use and a small private patient income stream via the Centre for Reproductive Medicine. The trust is governed as a public benefit entity with no external shareholders, and supplements public funding through the UHCW Charity and donations (such as Friends of St Cross contributions to the Fern Unit). Research is conducted via strategic partnerships with the University of Warwick, Warwick Medical School, University of Nottingham, and Imperial College London, and in January 2026 the trust co-launched VerIQ Limited, a University of Warwick spin-out focused on accelerating medtech and orthopaedics clinical trials across the UK.

University Hospitals Coventry and Warwickshire NHS Trust firmographics

Firmographics
Name
University Hospitals Coventry and Warwickshire NHS Trust
Legal name
University Hospitals Coventry and Warwickshire NHS Trust
Website
https://uhcw.nhs.uk
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
University Hospitals Coventry and Warwickshire NHS Trust is a public NHS acute hospital trust operating University Hospital Coventry and Hospital of St Cross Rugby, delivering comprehensive secondary and tertiary care to over one million residents in the West Midlands under NHS England commissioning.
Ownership category
akta.pro rank

University Hospitals Coventry and Warwickshire NHS Trust industry classification

Industry
Product category
Acute Hospital Healthcare Services
NAICS
General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (622110), Hospitals (622)
SIC
Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)
akta.pro primary industry
Faith-Based & Nonprofit Hospital Systems (HLAFAAAE)

Keywords

  • Acute hospital services
  • Emergency medical care
  • Diagnostic imaging services
  • Cancer treatment services
  • Maternity healthcare services

Where University Hospitals Coventry and Warwickshire NHS Trust is headquartered

Location

Headquarters

HQ city
Coventry
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

University Hospitals Coventry and Warwickshire NHS Trust business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

  1. NHS Core Funding: Core funding from the UK National Health Service through NHS England and NHS commissioning. Services are commissioned based on population health needs through the Coventry and Warwickshire Integrated Care System.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

University Hospitals Coventry and Warwickshire NHS Trust product offering

Product offering

Core offering

University Hospitals Coventry and Warwickshire NHS Trust (UHCW) operates two major NHS hospitals (University Hospital Coventry and Hospital of St Cross, Rugby) delivering comprehensive acute, emergency, elective, maternity, cancer, and specialist clinical services to a population of over one million people across Coventry and Warwickshire. The trust provides diagnostic imaging, interventional radiology, surgery, and specialized services including reproductive medicine, diabetes/endocrinology, and voice/swallowing care. It also conducts clinical research, trials, and innovation projects in partnership with UK universities.

Product overview

University Hospitals Coventry and Warwickshire NHS Trust operates as a large NHS hospital trust managing two major hospitals (University Hospital, Coventry and Hospital of St. Cross, Rugby) serving over a million people. The trust provides a comprehensive range of clinical services including emergency medicine, surgery, maternity, cancer care, and specialized services such as the Centre for Reproductive Medicine (IVF), WISDEM (diabetes/endocrinology/obesity), and interventional radiology. The trust has developed digital patient services including the myhealth Coventry and Warwickshire patient portal for online appointment booking and health records access, live waiting times tracking, and electronic patient record systems. The Performance & Informatics department has developed proprietary health technology tools including the HEARTT tool for health equity and waiting list management.

Differentiator

Problem solved

Functional benefit

Brands

  • UHCW Charity: Charitable arm of the trust supporting hospital services and equipment
  • WISDEM
  • Centre for Reproductive Medicine

Products and services

  • Centre for Reproductive Medicine
  • WISDEM
  • Coventry Voice, Swallowing and Airway Centre (CVASC)
  • Radiology Services
  • Interventional Radiology
  • myhealth Coventry and Warwickshire Patient Portal

Quantifiable outcome

  • 350,000+ diagnostic examinations performed annually across all imaging modalities
  • +2 more outcomes

Companies that use University Hospitals Coventry and Warwickshire NHS Trust

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles2 records

University Hospitals Coventry and Warwickshire NHS Trust technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

University Hospitals Coventry and Warwickshire NHS Trust partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core and major.

  • University of WarwickcoreStrategic or Co-development Partner · 11 January 2026Launched VerIQ Limited, a spin-out company in partnership with UHCW NHS Trust to accelerate the design, initiation, and delivery of clinical trials for medical devices and health technologies across the UK. Creating an integrated national clinical trial platform focused initially on orthopaedics and wider medtech trials.
  • Warwick Medical SchoolcoreStrategic or Co-development PartnerResearch partnership with researchers from University Hospitals Coventry and Warwickshire and Warwick Medical School presenting GLP-1 drug findings at ENDO 2026 conference.
  • University of NottinghammajorStrategic or Co-development PartnerLed the FreeDM2 clinical trial on continuous glucose monitoring for type 2 diabetes, with findings published in The Lancet Diabetes and Endocrinology.
  • Imperial College LondonmajorStrategic or Co-development PartnerCo-led the FreeDM2 clinical trial on continuous glucose monitoring for type 2 diabetes.
  • University of WarwickmajorStrategic or Co-development PartnerUniversity of Warwick-led study evaluating the Gro Health W8Buddy digital weight management pathway, NIHR-funded real-world patient-choice study recruiting 450 participants.
  • Friends of St CrosscoreStrategic or Co-development PartnerCharitable organization that donates equipment and volunteers to support the Hospital of St Cross. Donated over £70,000 to support the Fern Unit including a new ultrasound machine and two ultrasound couches.
  • XEOS (Belgian Company)coreTechnology or IntegrationManufacturer of the AURA 10 mobile PET-CT imager, first used in the UK at UHCW for intraoperative tumor margin assessment during cancer surgery.
  • University Hospitals Birmingham NHS Foundation TrustmajorStrategic or Co-development PartnerPartner trust in the SHiP-Rt study on shortened high-dose palliative radiotherapy for lung cancer.
  • University Hospitals of North Midlands NHS TrustmajorStrategic or Co-development PartnerPartner trust in the SHiP-Rt study on shortened high-dose palliative radiotherapy for lung cancer.
  • The Shrewsbury and Telford Hospital NHS TrustmajorStrategic or Co-development PartnerPartner trust in the SHiP-Rt study on shortened high-dose palliative radiotherapy for lung cancer.
  • Warwick Medical SchoolcoreStrategic or Co-development PartnerContributing oncologists, clinical scientists, radiotherapy physicists and radiobiology experts to the SHiP-Rt study.
  • IBMmajorTechnology or IntegrationCollaborative partner in developing the HEARTT tool and outpatient transformation, winning HSJ Best Healthcare Analytics Award 2024.
  • CelonismajorTechnology or IntegrationPartner in process mining for healthcare, enabling UHCW to become the first healthcare organization in Europe to leverage data mining effectively.
  • Coventry and Warwickshire Integrated Care SystemcoreStrategic or Co-development PartnerSystem partnership coordinating health and care services across the region, working with P&I Informatics team for timely and accurate intelligence.

Scale indicators5 records

Recent moves9 records

Expansion highlights6 records

University Hospitals Coventry and Warwickshire NHS Trust competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

University Hospitals Coventry and Warwickshire NHS Trust social profiles

Digital presence

University Hospitals Coventry and Warwickshire NHS Trust compliance and trust

Trust signal

Compliance2 records

University Hospitals Coventry and Warwickshire NHS Trust financial estimates

Financial estimate

Revenue estimate

Valuation estimate

University Hospitals Coventry and Warwickshire NHS Trust leadership team

Management profile

Number of profiles

Profiles10 records

University Hospitals Coventry and Warwickshire NHS Trust funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

University Hospitals Coventry and Warwickshire NHS Trust M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University Hospitals Coventry and Warwickshire NHS Trust

What does University Hospitals Coventry and Warwickshire NHS Trust do?

University Hospitals Coventry and Warwickshire NHS Trust (UHCW) operates two major NHS hospitals (University Hospital Coventry and Hospital of St Cross, Rugby) delivering comprehensive acute, emergency, elective, maternity, cancer, and specialist clinical services to a population of over one million people across Coventry and Warwickshire. The trust provides diagnostic imaging, interventional radiology, surgery, and specialized services including reproductive medicine, diabetes/endocrinology, and voice/swallowing care. It also conducts clinical research, trials, and innovation projects in partnership with UK universities.

Is University Hospitals Coventry and Warwickshire NHS Trust a public or private company?

University Hospitals Coventry and Warwickshire NHS Trust is a private company. It is classified as state government owned and is currently operating.

When was University Hospitals Coventry and Warwickshire NHS Trust founded?

University Hospitals Coventry and Warwickshire NHS Trust was founded in 2000. It employs 5,001 to 10,000 people.

Where is University Hospitals Coventry and Warwickshire NHS Trust based?

University Hospitals Coventry and Warwickshire NHS Trust is headquartered in Coventry, United Kingdom, in the Europe region.

How does University Hospitals Coventry and Warwickshire NHS Trust make money?

One revenue line is on record: NHS Core Funding.

Does University Hospitals Coventry and Warwickshire NHS Trust have an API?

No public API is recorded for University Hospitals Coventry and Warwickshire NHS Trust.

What industry is University Hospitals Coventry and Warwickshire NHS Trust in?

University Hospitals Coventry and Warwickshire NHS Trust's product category is Acute Hospital Healthcare Services. Its primary akta.pro industry code is HLAFAAAE, Faith-Based & Nonprofit Hospital Systems. Its NAICS code is 6221 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Folha'Fiz quimioterapia por 11 anos para tratar um câncer que eu não tinha'Becky Jones, 34, discovered she never had brain cancer but was treated for 11 years with chemotherapy after a wrongful diagnosis by a Coventry hospital doctor. She is among over 40 patients suing the University Hospitals Coventry and Warwickshire NHS Trust, with a Royal College of Physicians investigation finding 15 of 20 cases unsatisfactory.Express.co.ukUniversity Hospital Coventry declares critical incident as A&E wait times skyrocketUniversity Hospital Coventry declared a critical incident due to exceptionally high demand in its emergency department, with A&E waits exceeding six hours. The hospital urged patients to use the department only for life-threatening emergencies and to consider alternative services like NHS111.Tech TimesFrom Hospital Bed to Home: How WM5G is Tackling the NHS’s Delayed Discharge ProblemWM5G's Digital Discharge Service, a six-week supported recovery pathway, aims to reduce delayed hospital discharges. Modeling suggests it could prevent over 62,000 delayed discharges and save the NHS up to £157 million if scaled nationally. The service targets 600 referrals in Phase 1 across two West Midlands trusts.Mirage NewsGLP-1s Show Promise in Boosting Male FertilityResearchers from University Hospitals Coventry and Warwickshire and Warwick Medical School presented findings at ENDO 2026 in Chicago showing that GLP-1 drugs do not harm male hormones or fertility after long-term use, and may improve testosterone levels and sperm quality in men with obesity-related low testosterone. The meta-analysis of five randomized controlled trials found that semaglutide improved sperm shape and cholesterol over 24 weeks, while liraglutide increased testosterone in men over 16 weeks, outperforming testosterone replacement therapy alone. The researchers recommend treating the underlying cause—excess weight and poor metabolic health—rather than prescribing testosterone replacement, though they note larger studies are still needed.Med-Tech InsightsCalla Lily Clinical Care doses first patients in drug delivery platformCalla Lily Clinical Care dosed the first patients in the FREEDOM trial, which evaluates 400mg progesterone Callavid for luteal phase insufficiency. The study, funded by NIHR, aims to assess safety, user acceptability, and absorption of the leak-free vaginal delivery platform. The trial is led by Professor Siobhan Quenby.BBCGood rating for Coventry and Warwickshire hospitals trustUniversity Hospitals Coventry and Warwickshire NHS Trust retained its overall good rating despite NHS pressures, its CEO said. The CQC report found emergency care and children's services downgraded to requires improvement, with high demand on emergency services noted.ReviewedAnterior Interosseous Nerve to Pronator Quadratus Transfer to Restore Intrinsic Function: An Adjunct to Cubital Tunnel DecompressionA retrospective case series conducted at University Hospitals Coventry and Warwickshire evaluated the efficacy of combining anterior interosseous nerve to pronator quadratus (AINPQ) transfer with cubital tunnel decompression for severe ulnar neuropathy. The study found that all seven patients demonstrated motor function improvement, supporting the technique's potential to accelerate reinnervation and restore intrinsic hand function. The authors conclude that while results are promising, larger prospective studies are needed to validate patient selection criteria.National Center for Biotechnology InformationEvaluation of the Digital Support Tool Gro Health W8Buddy as Part of Tier 3 Weight Management Service: Observational StudyAn observational study evaluated the W8Buddy digital support tool within the NHS tier 3 weight management service at UHCW, finding that it led to statistically significant improvements in weight loss and HbA1c levels among users compared to traditional care. The tool demonstrated high patient engagement and positive impacts on life satisfaction and sleep quality, although the absolute weight loss was modest at 0.744 kg per month. This research highlights the potential of integrating free digital tools into clinical pathways to enhance chronic disease management and patient outcomes.Forbes IndiaWilliam Shakespeare has been vaccinated against the coronavirus. (Yes, you read that right)William Shakespeare, 81, of Warwickshire, received the Pfizer/BioNTech COVID-19 vaccine at University Hospital in Coventry, England, on December 8, 2020, as Britain began its largest vaccination campaign in history. He was the second person to be vaccinated, after the first recipient, and spoke briefly about the vaccine's potential impact.BBCCoventry mum's death after op blunder ruled 'misadventure'An inquest recorded a verdict of misadventure regarding the death of Deborah O'Hara, who died two days after a surgery at University Hospitals Coventry and Warwickshire NHS Trust to remove a kidney tumour. The coroner found that a surgical error involving an artery clip cut off blood supply to vital organs, leading to her death. The hospital trust has apologized and is expected to pay compensation following an internal investigation.